Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Aileron Therapeutics
281 Albany Street
Cambridge, MA 2139
Phone: 617-995-0900
www.aileronrx.com

Aileron Therapeutics is creating one of the first new classes of drugs in 20 years. Our proprietary Stapled Peptide drugs uniquely capitalize on 25 years of genetic research to attack the key drivers of complex diseases such as cancer, metabolic and endocrine conditions and inflammation. By harnessing one of the most common, but elusive, structures in nature - the alpha helical peptide, we believe that we can dramatically improve the treatment of these diseases and positively impact the lives of millions of patients.

Key Contact
Name
Joseph A. Yanchik
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
01/14/13 $42,000,000 Series D Apple Tree Partners
Excel Venture Management
Lilly Ventures
Novartis Venture Funds
Roche Venture Fund
SR One
undisclosed
11/18/13 $30,000,000 Series E Apple Tree Partners
Excel Venture Management
Lilly Ventures
Novartis Venture Funds
Roche Venture Fund
SR One
undisclosed
10/29/14 $33,000,000 Series E AJU IB Investment
Apple Tree Partners
Excel Venture Management
Lilly Ventures
Novartis Venture Funds
Roche Venture Fund
SR One
undisclosed


Featured Reading